Quote | Xilio Therapeutics Inc. (NASDAQ:XLO)
Last: | $1.09 |
---|---|
Change Percent: | -0.99% |
Open: | $1.02 |
Close: | $1.09 |
High: | $1.11 |
Low: | $1.02 |
Volume: | 143,939 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Xilio Therapeutics Inc. (NASDAQ:XLO)
2024-04-04 16:57:58 ET Summary Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to Gilead, but I wouldn't be surprised if Werewolf T...
2024-04-02 08:37:57 ET More on Pre-market losers & stocks. Hut 8 Mining Corp. (HUT) Q4 2023 Earnings Call Transcript From Bull To Bear: Recent Events Drove Me To Exit My Position In HUT 8 Hut 8 Post-Merger Comprehensive Thesis: JCapital Research Might Be Right ...
Message Board Posts | Xilio Therapeutics Inc. (NASDAQ:XLO)
Subject | By | Source | When |
---|---|---|---|
Price target > 36.00 > HC Wainwright | crudeoil24 | investorshub | 02/10/2022 8:10:07 PM |
TODAY > Xilio Therapeutics, Inc. (Nasdaq: XLO), a | crudeoil24 | investorshub | 02/10/2022 6:56:10 PM |
Xilio Therapeutics, Inc. is a biotechnology company. The | crudeoil24 | investorshub | 02/10/2022 6:51:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Xilio Therapeutics Inc. Company Name:
XLO Stock Symbol:
NASDAQ Market:
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quar...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 76.0% to $0.1065 on volume of 290,483,542 shares CXApp Inc. (CXAI) rose 151.0% to $6.15 on volume of 236,739,031 shares Nikola Corporation (NKLA) fell 1.0% to $1.03 on volume of 123,276,764 shares ...
On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer (MSS CRC) in the third quarter of 2024 Granted Gilead exclusive license to develop and ...